CM
BCYC

Caption Management’s Bicycle Therapeutics BCYC Stock Holding History

Caption Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-95,700
Closed -$2.04M – 1107
2023
Q1 		$2.04M Buy
+95,700
New +$2.4M 0.04% 439
2022
Q2 		– Sell
-205,900
Closed -$9.03M – 1456
2022
Q1 		$9.03M Buy
+205,900
New +$9.62M 0.11% 250

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Caption Management's BCYC Position: Q2 2025 in Review

Caption Management sold out of Bicycle Therapeutics (BCYC) in Q2 2025, closing a stake of 81,559 shares — an estimated $692K sold.

Caption Management first reported a position in BCYC in Q1 2022 and held it in 4 quarters. The position peaked at $2.28M in Q4 2024. 110 funds tracked by Wall St. Rank hold BCYC as of Q2 2025.

  • Caption Management reported no remaining Bicycle Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 81,559 Bicycle Therapeutics shares in Q2 2025, an estimated $692K.
  • Caption Management first reported a position in Bicycle Therapeutics in Q1 2022 and held it in 4 quarters.
  • Caption Management's Bicycle Therapeutics position peaked at $2.28M in Q4 2024.
  • 110 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.